Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionRehmann Capital Advisory Group
Latest Disclosed Ownership11,650 shares
Latest Disclosed Value $ 1,623,799
Rehmann Capital Advisory Group reports 3.15% increase in ownership of GILD / Gilead Sciences, Inc.

On May 15, 2026 - Rehmann Capital Advisory Group filed a 13F-HR form disclosing ownership of 11,650 shares of Gilead Sciences, Inc. (CH:GILD) valued at $1,623,799 USD as of March 31, 2026. The entity filed a previous 13F-HR on March 4, 2026 disclosing 11,294 shares of Gilead Sciences, Inc.. This represents a change in shares of 3.15% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GILEAD SCIENCES COM 375558103 11,650 356 3.15 1,624 17.10 0.0845
2026-03-04 2025-12-31 13F GILEAD SCIENCES COM 375558103 11,294 853 8.17 1,386 19.69 0.0722
2025-11-13 2025-09-30 13F GILEAD SCIENCES COM 375558103 10,441 10,441 1,159 0.0635
2025-07-30 2025-06-30 13F GILEAD SCIENCES COM 375558103 0 -10,073 -100.00 0 -100.00
2025-04-30 2025-03-31 13F GILEAD SCIENCES COM 375558103 10,073 81 0.81 1,129 22.34 0.0711
2025-02-14 2024-12-31 13F GILEAD SCIENCES COM 375558103 9,992 366 3.80 923 14.25 0.0585
2024-11-18 2024-09-30 13F GILEAD SCIENCES COM 375558103 9,626 333 3.58 807 26.69 0.0528
2024-08-12 2024-06-30 13F GILEAD SCIENCES COM 375558103 9,293 -1,117 -10.73 638 -16.40 0.0457
2024-05-03 2024-03-31 13F GILEAD SCIENCES COM 375558103 10,410 -2,048 -16.44 763 -24.48 0.0569
2024-02-13 2023-12-31 13F GILEAD SCIENCES COM 375558103 12,458 450 3.75 1,009 12.24 0.0836
2023-11-14 2023-09-30 13F GILEAD SCIENCES COM 375558103 12,008 -717 -5.63 900 -8.27 0.0838
2023-08-23 2023-06-30 13F/A-1 GILEADSCIENCESINC COM 375558103 12,725 76 0.60 981 -6.58 0.0879
2023-08-15 2023-06-30 13F GILEAD SCIENCES COM 375558103 12,649 0 1,050 0.0987
2023-05-12 2023-03-31 13F GILEAD SCIENCES COM 375558103 12,649 78 0.62 1,050 -2.78 0.0987
2023-02-10 2022-12-31 13F GILEAD SCIENCES COM 375558103 12,571 143 1.15 1,079 40.86 0.1106
2022-11-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 12,428 999 8.74 767 8.50 0.0850
2022-08-12 2022-06-30 13F GILEAD SCIENCES COM 375558103 11,429 2,157 23.26 706 24.96 0.0777
2022-06-03 2022-03-31 13F GILEAD SCIENCES COM 375558103 9,272 -2,300 -19.88 566 -32.98 0.0538
2022-03-02 2021-12-31 13F GILEAD SCIENCES GILD 375558103 11,572 488 4.40 844 8.91 0.0784
2021-11-16 2021-09-30 13F GILEAD SCIENCES COM 375558103 11,084 -1,277 -10.33 774 -9.05 0.0734
2021-08-13 2021-06-30 13F GILEAD SCIENCES COM 375558103 12,361 423 3.54 852 8.55 0.0824
2021-05-26 2021-03-31 13F GILEAD SCIENCES COM 375558103 11,938 -503 -4.04 785 8.29 0.0802
2021-02-19 2020-12-31 13F GILEAD SCIENCES COM 375558103 12,441 -11,375 -47.76 725 -51.86 0.0818
2020-11-19 2020-09-30 13F GILEAD SCIENCES COM 375558103 23,816 10,227 75.26 1,505 43.92 0.1909
2020-11-20 2020-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 13,589 887 6.98 1,046 10.12 0.1427
2020-08-25 2020-06-30 13F GILEAD SCIENCES COM 375558103 3,856 0 288 152,276.3868
2020-11-20 2020-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 12,702 1,078 9.27 950 28.94 0.1550
2020-08-24 2020-03-31 13F GILEAD SCIENCES COM 375558103 3,856 -7,768 288 160,815.5731
2020-01-02 2019-09-30 13F GILEAD SCIENCES COM 375558103 11,624 -152 -1.29 737 -7.42 0.0891
2019-08-27 2019-06-30 13F GILEAD SCIENCES COM 375558103 11,776 -130 -1.09 796 2.71 0.0980
2019-05-22 2019-03-31 13F GILEAD SCIENCES COM 375558103 11,906 203 1.73 774 5.74 0.1049
2019-02-12 2018-12-31 13F GILEAD SCIENCES COM 375558103 11,703 -1,570 -11.83 732 -28.52 0.1098
2018-12-07 2018-09-30 13F/A-1 GILEADSCIENCESINC COM 375558103 13,273 -651 -4.68 1,025 3.85 0.1413
2018-09-20 2018-06-30 13F GILEAD SCIENCES COM 375558103 13,924 -9,028 -39.33 986 -43.01 0.1432
2018-04-24 2018-03-31 13F GILEAD SCIENCES COM 375558103 22,952 -723 -3.05 1,730 2.00 0.2693
2018-02-22 2017-12-31 13F GILEAD SCIENCES COM 375558103 23,675 -750 -3.07 1,696 -14.30 0.2861
2017-10-25 2017-09-30 13F GILEAD SCIENCES COM 375558103 24,425 982 4.19 1,979 19.29 0.3568
2017-07-19 2017-06-30 13F GILEAD SCIENCES COM 375558103 23,443 -836 -3.44 1,659 0.61 0.3169
2017-04-24 2017-03-31 13F GILEAD SCIENCES COM 375558103 24,279 4,423 22.28 1,649 15.96 0.2752
2017-02-13 2016-12-31 13F GILEAD SCIENCES COM 375558103 19,856 4,874 32.53 1,422 20.00 0.2602
2016-10-26 2016-09-30 13F GILEAD SCIENCES COM 375558103 14,982 -3,983 -21.00 1,185 -25.09 0.2296
2016-07-25 2016-06-30 13F GILEAD SCIENCES COM 375558103 18,965 -1,194 -5.92 1,582 -14.58 0.2961
2016-05-09 2016-03-31 13F GILEAD SCIENCES COM 375558103 20,159 798 4.12 1,852 -5.46 0.3606
2016-02-11 2015-12-31 13F GILEAD SCIENCES COM 375558103 19,361 -2,032 -9.50 1,959 -6.76 0.4115
2015-11-12 2015-09-30 13F GILEAD SCIENCES COM 375558103 21,393 1,473 7.39 2,101 -9.91 0.4752
2015-07-08 2015-06-30 13F GILEAD SCIENCES COM 375558103 19,920 2,448 14.01 2,332 35.98 0.5322
2015-04-14 2015-03-31 13F GILEAD SCIENCES COM 375558103 17,472 838 5.04 1,715 9.38 0.3891
2015-03-09 2014-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 16,634 -770 -4.42 1,568 -15.38 0.3609
2015-09-01 2014-09-30 13F GILEAD SCIENCES COM 375558103 17,404 899 5.45 1,853 35.45 0.4388
2015-09-01 2014-06-30 13F GILEAD SCIENCES COM 375558103 16,505 922 5.92 1,368 23.91 0.3266
2015-08-31 2014-03-31 13F GILEAD SCIENCES COM 375558103 15,583 1,996 14.69 1,104 8.24 0.2984
2015-08-31 2013-12-31 13F GILEAD SCIENCES COM 375558103 13,587 -343 -2.46 1,020 16.44 0.3086
2015-08-31 2013-09-30 13F GILEAD SCIENCES COM 375558103 13,930 -162 -1.15 876 21.33 0.2834
2015-08-31 2013-06-30 13F GILEAD SCIENCES COM 375558103 14,092 3,821 37.20 722 43.54 0.2506
2015-08-31 2013-03-31 13F GILEAD SCIENCES COM 375558103 10,271 4,392 74.71 503 16.44 0.1800
2015-08-31 2012-12-31 13F GILEAD SCIENCES COM 375558103 5,879 951 19.30 432 32.11 0.1721
2015-08-31 2012-09-30 13F GILEAD SCIENCES COM 375558103 4,928 -194 -3.79 327 24.33 0.1201
2015-08-31 2012-06-30 13F GILEAD SCIENCES COM 375558103 5,122 306 6.35 263 11.91 0.0864
2015-08-31 2012-03-31 13F GILEAD SCIENCES COM 375558103 4,816 -299 -5.85 235 12.44 0.0715
2015-08-31 2011-12-31 13F GILEAD SCIENCES COM 375558103 5,115 5,115 209 0.0670
2015-08-31 2010-06-30 13F GILEAD SCIENCES COM 375558103 0 0 0 0.0000
2015-08-27 2010-03-31 13F GILEAD SCIENCES COM 375558103 0 -4,826 -100.00 0 -100.00
2015-08-27 2009-12-31 13F GILEAD SCIENCES COM 375558103 4,826 -3,023 -38.51 209 -42.74 0.1352
2015-08-27 2009-09-30 13F GILEAD SCIENCES COM 375558103 7,849 -2,494 -24.11 365 -24.59 0.2254
2015-08-27 2009-06-30 13F GILEAD SCIENCES COM 375558103 10,343 942 10.02 484 12.82 0.4052
2015-08-27 2009-03-31 13F GILEAD SCIENCES COM 375558103 9,401 -261 -2.70 429 -13.16 0.5115
2015-08-27 2008-12-31 13F GILEAD SCIENCES COM 375558103 9,662 9,662 494 0.4398
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.